Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 2/20 | 0.44 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.42 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.40 |
| ▸ | CAMKK2 | Q96RR4 | 3/20 | 0.40 |
| ▸ | CAMKK1 | Q8N5S9 | 2/20 | 0.40 |
| ▸ | IP6K1 | Q92551 | 6/20 | 0.40 |
| ▸ | IP6K3 | Q96PC2 | 6/20 | 0.40 |
| ▸ | IP6K2 | Q9UHH9 | 6/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.37 |
| ▸ | PLAU | P00749 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9907398 | 0.85 | ALOX15 (0.46) | PIK3CASLC22A12CAMKK2ALDH1A1KDM4E | |
| SCHEMBL9907326 | 0.83 | PIK3CA (0.57) | PIK3CACAMKK2CAMKK1IP6K1IP6K3 | |
| SCHEMBL9907815 | 0.83 | HTR5A (0.42) | PIK3CASLC22A12PLAUIKBKBCHUK | |
| SCHEMBL9907407 | 0.83 | CYP19A1 (0.38) | SLC22A12IP6K1IP6K3IP6K2MEN1 | |
| SCHEMBL9909160 | 0.79 | SLC22A12 (0.58) | PIK3CASLC22A12MAPKAPK2CAMKK2CAMKK1 | |
| SCHEMBL9907345 | 0.78 | KDM4C (0.41) | PIK3CACAMKK2CAMKK1IP6K1IP6K3 | |
| SCHEMBL9907577 | 0.76 | SLC22A12 (0.40) | SLC22A12MAPKAPK2IP6K1IP6K3IP6K2 | |
| SCHEMBL9907412 | 0.74 | KMO (0.50) | PIK3CAMAPKAPK2CAMKK2CAMKK1IP6K1 | |
| SCHEMBL9907411 | 0.74 | MPL (0.45) | PIK3CASLC22A12MAPKAPK2CAMKK2CAMKK1 | |
| SCHEMBL9909215 | 0.74 | RXRA (0.52) | SLC22A12IP6K1IP6K3IP6K2ALKBH5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8853242-B2 | Nitrogenous-ring acylguanidine derivative | ASTELLAS PHARMA INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20120142727-A1 | NITROGENOUS-RING ACYLGUANIDINE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142727-A1 | NITROGENOUS-RING ACYLGUANIDINE DERIVATIVE | HTR5A, HTR2A, HTR1E | PIK3CA 3492/4885SLC22A12 1751/4885MAPKAPK2 4333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.